Lactate dehydrogenase to albumin ratio and poor prognosis after thrombolysis in ischemic stroke patients: developing a novel nomogram

• Published in: BMC medical informatics and decision making Vol. 25; no. 1; pp. 166 - 10
• Main Authors: Zhang, Xiao-Dan, Zhang, Zong-Yong, Zhao, Ming-Pei, Zhang, Xiang-Tao, Wang, Neng, Gao, Hong-Zhi, Lin, Yuan-Xiang, Zheng, Zong-Qing
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 15.04.2025; BioMed Central; BMC
• Subjects: Accuracy; Aged; Albumin; Albumins; Blood pressure; Brain research; Calibration; Care and treatment; Dehydrogenase; Dehydrogenases; Diagnosis; Disability; Enzymes; Ethics; Evaluation; Female; Health aspects; Humans; Indicators; Ischemia; Ischemic stroke; Ischemic Stroke - blood; Ischemic Stroke - diagnosis; Ischemic Stroke - drug therapy; Ischemic Stroke - therapy; Kinases; L-Lactate dehydrogenase; L-Lactate Dehydrogenase - blood; Lactate dehydrogenase; Lactic acid; LAR; Leukocytes; Male; Measurement; Medical prognosis; Middle Aged; Mortality; Nomograms; Patient outcomes; Patients; Prediction models; Prognosis; Proteins; Regression analysis; Retrospective Studies; Serum albumin; Serum Albumin - analysis; Statistical analysis; Stroke; Stroke (Disease); Thrombolysis; Thrombolytic drugs; Thrombolytic Therapy; Tissues; Transient ischemic attack; Variables; Veins & arteries; China; Albumin; Lactate dehydrogenase; Ischemic stroke; LAR
• ISSN: 1472-6947; 1472-6947
• DOI: 10.1186/s12911-025-02991-z

Ischemic stroke (IS) is associated with high disability and mortality. This study aimed to identify the prognostic predictors and develop a nomogram for a prediction model for ischemic stroke patients after thrombolysis. We retrospectively analyzed data from 359 IS patients who underwent thrombolysis. Clinical characteristics, laboratory parameters, and prognosis data were collected. One-third of the subjects were randomly selected as a validation set (n = 108) for internal validation. Logistic regression analysis was used to derive independent risk indicators. A nomogram was constructed using these indicators, and the performance of the nomogram was assessed by the Area Under the Curve (AUC) of the Receiver Operating Characteristic (ROC). The agreement of the model predictions with actual observations was assessed via calibration curves, and the clinical utility of the nomogram was assessed via decision curve analysis. Multivariate logistic regression analysis showed that age, leukocytes, Lactate Dehydrogenase to Albumin Ratio (LAR) and NIHSS were independent predictors of three-month post-thrombolysis prognosis in IS patients. We created a nomogram based on the weighting coefficients of these factors. The AUC curves showed that our model including age, leukocytes, LAR and NIHSS was more accurate in predicting prognosis than a single factor. The calibration curves showed a good fit between actual and predicted probabilities in both the training and validation groups. LAR has a good predictive power for the prognosis of IS patients 3 months after thrombolytic therapy and can be used as a new clinical indicator to establish a practical nomogram.